Chester County News and Community Website
WASHINGTON D.C. — The U.S. Food and Drug Administration (FDA) has made a landmark decision to approve Aqneursa (levacetylleucine) for the treatment of neurological symptoms linked to Niemann-Pick disease type C …
FDA Greenlights Aqneursa for Niemann-Pick Disease Type C, Marking a Breakthrough in Rare Disease Treatment Read More
WASHINGTON, D.C. — The Food and Drug Administration announced that Truly Good Foods has recalled its Grabeez The Big Cheese Snack Mix after discovering undeclared almonds and cashews in the …
Truly Good Foods Issues Recall for Grabeez The Big Cheese Snack Mix Due to Allergy Concerns Read More
WASHINGTON, D.C. — Gilead Sciences, Inc. (Nasdaq: GILD) has announced a voluntary recall of one lot of its COVID-19 treatment drug, Veklury® (remdesivir) for Injection 100 mg/vial, following the discovery …
Glass Alert in COVID-19 Drug: Gilead’s Swift Recall to Protect Patients Read More
WASHINGTON, D.C. — Lystn, LLC, operating as ANSWERS Pet Food of Fleetwood, PA, has announced the voluntary withdrawal of specific lots of its pet food products. This decision follows the …
Contaminated Pet Food Alert: ANSWERS Takes Steps to Protect Pets and Owners Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved FluMist for self- or caregiver-administration, expanding accessibility for influenza prevention. FluMist, designed to combat influenza virus subtypes A and …
FDA Greenlights FluMist for Self- and Caregiver-Administration Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Miplyffa (arimoclomol) for the treatment of Niemann-Pick disease, type C (NPC), marking the first drug sanctioned to address …
FDA Approves Miplyffa for Niemann-Pick Disease, Type C Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently unveiled a draft guidance designed to enhance multiregional clinical trials (MRCTs) in oncology, aimed at improving data relevance for …
FDA Issues Draft Guidance on Multiregional Clinical Trials in Oncology Read More
WASHINGTON, D.C. — In a recent announcement by the Food and Drug Administration, Dynarex Corporation has initiated a recall of 62 cases of its Dynacare Baby Powder due to potential …
Urgent Recall: Dynacare Baby Powder Pulled Over Asbestos Concerns Read More
WASHINGTON, D.C. — Bionpharma Inc. this week announced a voluntary recall of a single batch of Atovaquone Oral Suspension, 750mg per mL, due to contamination with Cohnella bacteria. This recall, …
Your Safety First: What You Need to Know About Bionpharma’s Urgent Atovaquone Recall Read More
WASHINGTON, D.C. — In a groundbreaking move aimed at enhancing accessibility and innovation in hearing aid technology, the U.S. Food and Drug Administration (FDA) recently authorized the first over-the-counter (OTC) …
Revolutionary Hearing Aid Software Turns AirPods Pro into Accessible Hearing Solutions! Read More